グルカゴンとGLP-1は,仮小島組成を加速し,性別小島断片化ダイナミクスを明らかにする
bioRxiv : the preprint server for biology
|August 20, 2025
まとめ
グルカゴン (GCG) とグルカゴン類ペプチド-1 (GLP-1) は,ヒトの小島細胞の集積と構造的整合に影響を与える. これらのホルモンは,偽小島形成を促進し,性別の方法でネイティブ小島断片化に影響を与え,糖尿病研究に影響を与えます.
科学分野:
- 内分泌学と代謝
- 細胞生物学と組織工学
背景:
- グルカゴン (GCG) やグルカゴン型ペプチド-1 (GLP-1) のような臓ホルモンは,血糖の調節に不可欠です.
- 特にヒトの小島における細胞集積の維持と誘発におけるそれらの役割は完全に理解されていません.
- 培養中の小島細胞の行動を理解することは,糖尿病の研究と治療の開発に不可欠です.
研究 の 目的:
- 培養におけるヒト小島群の形成と整体性に対するGCGとGLP-1の影響を調査する.
- 島の形態形成,建築,細胞間信号伝達の研究のための人間の擬似島プラットフォームを確立する.
- 細胞組成とドナーの性別が,ホルモン媒介による小島構造への影響を評価する.
主な方法:
- ヒトの小島は,光活性化細胞分類 (FACS) を使用して分離され,純粋なα,β,およびδ細胞集団に分類された.
- 分類された細胞は,マウス内皮のMS1細胞と共同培養して,擬似小島を生成した.
- 培養中にGCGまたはGLP-1のホルモン補給が投与され,本来の小島も治療された.
主要な成果:
- ホルモンで治療された偽島はより速く形成され,その効果は細胞組成とドナーの性別に依存する.
- ホルモンで治療された本来の小島は,女性ドナーで加速した断片化を示したが,男性ドナーでは弱まった断片化を示した.
- 細胞組成によって決定され,ドナーの性別が二次的要因であった.
結論:
- GCGとGLP-1は,擬似小島形成を強化し,本来のヒト小島の構造的整合性を調節する.
- これらのホルモンの作用は性別に特異的にあり,ドナーの男性と女性の島の行動に異なった影響を及ぼします.
- この研究は,ヒトの擬似小島生成のための方法論的ガイドラインを提供し,糖尿病の研究の枠組みを提供し,実験設計を最適化します.
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K


